Bengaluru, August 06, 2018: Narayana Hrudayalaya Limited, a leading healthcare service provider in India, today announced its financial results for the first quarter (Q1 FY19) ended June 30th, 2018.
Financial Highlights for the Quarter (Q1 FY19) – Prepared in accordance with Ind AS (‘Indian Accounting Standards’)
· Consolidated total operating income was Rs 6,523 mn for Q1 FY19 as compared to Rs 5,211 mn in the corresponding period of the previous year, reflecting an increase of 25.2%
· Consolidated EBITDA stood at Rs 504 mn, reflecting a margin of 7.7%
As on June 30th, 2018, the consolidated net debt was Rs 7,943 mn representing a net debt to equity ratio of 0.76. (Out of which, debt worth US$ 57.8 mn is foreign currency denominated).
Other Highlights during the Quarter
· Mazumdar Shaw Medical Centre, Bengaluru operated a case of Naso Orbital Solitary Fibrous tumor using trans-nasal endo-orbital approach. Only 30 such cases have been reported in the world with this being the 2nd case operated by endoscopic approach
· Narayana Institute of Cardiac Sciences, Bengaluru performed a double lung transplant. With novel techniques like these, the facility has emerged as the prime centre for organ transplants
· A one of its kind knee replacement surgery in the city was performed at Narayana Multispeciality Hospital, Jaipur in which special type of implants were used as the patient was allergic to metal
· Mazumdar Shaw Medical Centre, Bengaluru performed postaural approach, Robotic Neck Dissection. This approach does not lead to visible scars in the neck and the incision is hidden in the hairline
· Health City Cayman Islands won the silver award in Direct Care Providers category at Health Value Awards conducted by World Health Care Congress in April 2018
· RTIICS, Kolkata was ranked 2nd in the Eastern Region in the All India Multispeciality Hospitals Ranking Survey 2018 by Times of India in June 2018
Management Comment
Commenting on the performance, Dr. Ashutosh Raghuvanshi, Vice Chairman, Managing Director and Group CEO, Narayana Hrudayalaya Limited, said “The results of the first quarter of fiscal year 2019 are broadly in line with our expectations, barring that of our international venture, HCCI whose performance was hit by transient operational issues. With the recent commissioning of our Gurugram facility, we now have 3 new super-specialty hospitals across the critical markets of Delhi NCR and Mumbai and have thus entered into a phase of consolidation of Indian operations. With newer centres gaining traction in terms of ramp-up in patients’ footfalls, we continue to be excited about our emerging northern and western clusters and thus evolve as a truly pan-India healthcare provider.
On the clinical front, we remain committed to creating regional Centres of Excellences’ by focusing on advanced quaternary care and thus continue to invest in state-of-the-art medical technology across niche specialties such as Oncology and Cardiac Sciences through attractive financing solutions. Overall, we remain confident about the prospects of Indian healthcare ecosystem and our ability to deliver quality affordable solution to all sections of the society.”
Corporate Comm India(CCI Newswire)
